EyePoint (EYPT) Revenue (2010 - 2026)

EyePoint (EYPT) reported Revenue of $696000.0 for Q1 2026, down 97.15% on a YoY basis from $24.5 million in Q1 2025, and up 12.26% sequentially from $620000.0 in Q4 2025.

EyePoint (EYPT) Revenue (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 17 years of Revenue data on file, last reported at $696000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Revenue fell 97.15% year-over-year to $696000.0; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 86.41% YoY), and the FY2025 full-year result was $31.4 million, down 27.5% from the prior year.
  • Revenue climbed to $696000.0 in Q1 2026, from $620000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $24.5 million in Q1 2025 to a low of $620000.0 in Q4 2025.
  • A 5-year average of $9.6 million and a median of $10.0 million in 2022 frame the typical range for Revenue.
  • Across the five-year window, Revenue soared 109.29% in 2025 and tumbled 97.15% in 2026, its largest moves.
  • Tracing EYPT's Revenue over 5 years: stood at $10.5 million in 2022, then soared by 33.18% to $14.0 million in 2023, then retreated by 17.39% to $11.6 million in 2024, then plunged by 94.65% to $620000.0 in 2025, then climbed by 12.26% to $696000.0 in 2026.
  • Business Quant data shows EYPT's Revenue at $696000.0 in Q1 2026, $620000.0 in Q4 2025, and $966000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 696,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 696,000.00
Dec 31, 2025 620,000.00
Sep 30, 2025 966,000.00
Jun 30, 2025 5.33 Mn
Mar 31, 2025 24.45 Mn
Dec 31, 2024 11.59 Mn
Sep 30, 2024 10.52 Mn
Jun 30, 2024 9.48 Mn
Mar 31, 2024 11.68 Mn
Dec 31, 2023 14.03 Mn
Sep 30, 2023 15.20 Mn
Jun 30, 2023 9.11 Mn
Mar 31, 2023 7.68 Mn
Dec 31, 2022 10.53 Mn
Sep 30, 2022 10.01 Mn
Jun 30, 2022 11.57 Mn
Mar 31, 2022 9.29 Mn
Dec 31, 2021 11.54 Mn
Sep 30, 2021 9.06 Mn
Jun 30, 2021 9.01 Mn